SlideShare a Scribd company logo
1 of 7
Helping our customers to improve the lives of psychiatric patients by offering the most predictive in-vivo screens to discover the next generation of therapeutic compounds,[object Object],Suite 016/018, Kompleks EUREKA, Universiti Sains Malaysia, 11800 Penang, Malaysia,[object Object],Tel: +604-659 1926   •   Fax: +604-659 1927  •  www.chakrabiotech.com.my,[object Object]
Discovery Pharmacology,[object Object],2,[object Object],How can we be sure the drug is safe and effective enough to warrant:,[object Object],1. Risks to volunteers/patients 2. Development risks? ,[object Object],Current medications,[object Object],“Clearly the treatment armamentarium is by no means complete or satisfactory, and individuals require more, not fewer options.”  US FDA,[object Object],“The improvement in medication has not changed the proportion of schizophrenics who maintain a steady job, about 10% - about the same proportion who suicide.” Neuroinvestments,[object Object]
Key Technology (1/2),[object Object],3,[object Object]
Key Technology (2/2),[object Object],4,[object Object]
The Pharma Value Chain,[object Object],5,[object Object]
Chakra Biotech Sdn Bhd,[object Object],2007 - Founded,[object Object],Spin-out of discovery platform to allow commercialisation,[object Object],Granted Bionexus status from the Malaysian Biotech Corporation (MBC) in 2007,[object Object],2008 - Funded,[object Object],Awarded Seed Fund Commercialisation Grant of RM2.5m,[object Object],Obtained venture capital funding from MLSCF and MTDC,[object Object],2009 – Building platform,[object Object],Chakra Biotech was officially opened 11th March 2009 by the Fadilah Yusof, Deputy Minister for Science, Technology and Innovation on behalf of the Minister ,[object Object],First revenues,[object Object],2010 - Expansion,[object Object],Major expansion of capacity and further research planned for 2010,[object Object],6,[object Object]
Opportunities for Malaysia,[object Object],Waves of Opportunity,[object Object],Unmet patients needs: drives pharma,[object Object],Outsourcing: increasing by ~15% p.a.,[object Object],Asia: increasing importance for R&D and markets,[object Object],Malaysia – Catching the Waves,[object Object],Attention - earliest part of pharma value chain,[object Object],Employment – more than scientists,[object Object],7,[object Object]

More Related Content

Similar to 09 CeoMeeting- Session 4- Chakra

Cns clinical trials (2010)
Cns clinical trials (2010)Cns clinical trials (2010)
Cns clinical trials (2010)jaayboy69
 
Vaccine research & innovation
Vaccine research &  innovationVaccine research &  innovation
Vaccine research & innovationjaayboy69
 
OneStart Top 10 Finalists
OneStart Top 10 FinalistsOneStart Top 10 Finalists
OneStart Top 10 Finalistsjohndaley89
 
One start finalists
One start finalistsOne start finalists
One start finalistsjohndaley89
 
Patient Education Needs From Markiv
Patient Education Needs From MarkivPatient Education Needs From Markiv
Patient Education Needs From MarkivDr Neelesh Bhandari
 
Quintain Consulting Presentation
Quintain Consulting PresentationQuintain Consulting Presentation
Quintain Consulting Presentationjeanettepritchard
 
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...PharmaLedger
 
The new clinical trials regulation and regulatory affairs
The new clinical trials regulation and regulatory affairsThe new clinical trials regulation and regulatory affairs
The new clinical trials regulation and regulatory affairsGlobalCompliancePanel
 
MKTG Corporate Standard Presentation
MKTG Corporate Standard PresentationMKTG Corporate Standard Presentation
MKTG Corporate Standard PresentationKel' Laquian
 
Phision Theraputics
Phision TheraputicsPhision Theraputics
Phision TheraputicsInvestnet
 
Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014healthtechqld
 
BioMedETC-2015Report-1.1.compressed(1)
BioMedETC-2015Report-1.1.compressed(1)BioMedETC-2015Report-1.1.compressed(1)
BioMedETC-2015Report-1.1.compressed(1)Teck Ee Keng
 
UoB Business Club Breakfast Briefing - November 2017
UoB Business Club Breakfast Briefing - November 2017UoB Business Club Breakfast Briefing - November 2017
UoB Business Club Breakfast Briefing - November 2017Nathalie Kopecky
 
Myren medical talk 2011
Myren medical talk 2011Myren medical talk 2011
Myren medical talk 2011Alan Teh
 
Nanopharmaceutical & its_industrial_applications_program-ppt
Nanopharmaceutical & its_industrial_applications_program-pptNanopharmaceutical & its_industrial_applications_program-ppt
Nanopharmaceutical & its_industrial_applications_program-ppttabirsir
 

Similar to 09 CeoMeeting- Session 4- Chakra (20)

Cns clinical trials (2010)
Cns clinical trials (2010)Cns clinical trials (2010)
Cns clinical trials (2010)
 
Vaccine research & innovation
Vaccine research &  innovationVaccine research &  innovation
Vaccine research & innovation
 
OneStart Top 10 Finalists
OneStart Top 10 FinalistsOneStart Top 10 Finalists
OneStart Top 10 Finalists
 
One start finalists
One start finalistsOne start finalists
One start finalists
 
Medtronic
MedtronicMedtronic
Medtronic
 
Platform Update
Platform UpdatePlatform Update
Platform Update
 
Patient Education Needs From Markiv
Patient Education Needs From MarkivPatient Education Needs From Markiv
Patient Education Needs From Markiv
 
Quintain Consulting Presentation
Quintain Consulting PresentationQuintain Consulting Presentation
Quintain Consulting Presentation
 
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
 
OneStart 2013 Finalists (Europe)
OneStart 2013 Finalists (Europe)OneStart 2013 Finalists (Europe)
OneStart 2013 Finalists (Europe)
 
000519 csfb e medasiaroadshowfinal9 hm
000519 csfb e medasiaroadshowfinal9 hm000519 csfb e medasiaroadshowfinal9 hm
000519 csfb e medasiaroadshowfinal9 hm
 
The new clinical trials regulation and regulatory affairs
The new clinical trials regulation and regulatory affairsThe new clinical trials regulation and regulatory affairs
The new clinical trials regulation and regulatory affairs
 
MKTG Corporate Standard Presentation
MKTG Corporate Standard PresentationMKTG Corporate Standard Presentation
MKTG Corporate Standard Presentation
 
Phision Theraputics
Phision TheraputicsPhision Theraputics
Phision Theraputics
 
Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014
 
BioMedETC-2015Report-1.1.compressed(1)
BioMedETC-2015Report-1.1.compressed(1)BioMedETC-2015Report-1.1.compressed(1)
BioMedETC-2015Report-1.1.compressed(1)
 
UoB Business Club Breakfast Briefing - November 2017
UoB Business Club Breakfast Briefing - November 2017UoB Business Club Breakfast Briefing - November 2017
UoB Business Club Breakfast Briefing - November 2017
 
Myren medical talk 2011
Myren medical talk 2011Myren medical talk 2011
Myren medical talk 2011
 
Nanopharmaceutical & its_industrial_applications_program-ppt
Nanopharmaceutical & its_industrial_applications_program-pptNanopharmaceutical & its_industrial_applications_program-ppt
Nanopharmaceutical & its_industrial_applications_program-ppt
 
Biobanking 2011
Biobanking 2011Biobanking 2011
Biobanking 2011
 

More from MLSCF

09 CeoMeeting- Final Talk_Jay Keasling
09 CeoMeeting- Final Talk_Jay Keasling09 CeoMeeting- Final Talk_Jay Keasling
09 CeoMeeting- Final Talk_Jay KeaslingMLSCF
 
09 CeoMeeting- Session 5- Biotech Corp
09 CeoMeeting- Session 5- Biotech Corp09 CeoMeeting- Session 5- Biotech Corp
09 CeoMeeting- Session 5- Biotech CorpMLSCF
 
09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- Abunda09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- AbundaMLSCF
 
09 CeoMeeting- Session 4- Sentinext
09 CeoMeeting- Session 4- Sentinext09 CeoMeeting- Session 4- Sentinext
09 CeoMeeting- Session 4- SentinextMLSCF
 
09 CeoMeeting- Session 4- Artisan
09 CeoMeeting- Session 4- Artisan09 CeoMeeting- Session 4- Artisan
09 CeoMeeting- Session 4- ArtisanMLSCF
 
09 CeoMeeting- Session 3- Dr. Kishore
09 CeoMeeting- Session 3- Dr. Kishore09 CeoMeeting- Session 3- Dr. Kishore
09 CeoMeeting- Session 3- Dr. KishoreMLSCF
 
09 CeoMeeting- Session 3- Sime Darby
09 CeoMeeting- Session 3- Sime Darby09 CeoMeeting- Session 3- Sime Darby
09 CeoMeeting- Session 3- Sime DarbyMLSCF
 
09 CeoMeeting- Session 3- Chromatin
09 CeoMeeting- Session 3- Chromatin09 CeoMeeting- Session 3- Chromatin
09 CeoMeeting- Session 3- ChromatinMLSCF
 
09 CeoMeeting- Session 3- Metahelix
09 CeoMeeting- Session 3- Metahelix09 CeoMeeting- Session 3- Metahelix
09 CeoMeeting- Session 3- MetahelixMLSCF
 
09 CeoMeeting- Session1- Cobalt
09 CeoMeeting- Session1- Cobalt09 CeoMeeting- Session1- Cobalt
09 CeoMeeting- Session1- CobaltMLSCF
 
09 CeoMeeting- Session1- Segetis
09 CeoMeeting- Session1- Segetis09 CeoMeeting- Session1- Segetis
09 CeoMeeting- Session1- SegetisMLSCF
 
09 CeoMeeting- Session1- Gevo
09 CeoMeeting- Session1- Gevo09 CeoMeeting- Session1- Gevo
09 CeoMeeting- Session1- GevoMLSCF
 
09 CeoMeeting- Session 2- Hovid
09 CeoMeeting- Session 2- Hovid09 CeoMeeting- Session 2- Hovid
09 CeoMeeting- Session 2- HovidMLSCF
 
09 CeoMeeting- Session2- Battelle
09 CeoMeeting- Session2- Battelle09 CeoMeeting- Session2- Battelle
09 CeoMeeting- Session2- BattelleMLSCF
 
09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- MascomaMLSCF
 
09 CeoMeeting- Keynote
09 CeoMeeting- Keynote09 CeoMeeting- Keynote
09 CeoMeeting- KeynoteMLSCF
 

More from MLSCF (16)

09 CeoMeeting- Final Talk_Jay Keasling
09 CeoMeeting- Final Talk_Jay Keasling09 CeoMeeting- Final Talk_Jay Keasling
09 CeoMeeting- Final Talk_Jay Keasling
 
09 CeoMeeting- Session 5- Biotech Corp
09 CeoMeeting- Session 5- Biotech Corp09 CeoMeeting- Session 5- Biotech Corp
09 CeoMeeting- Session 5- Biotech Corp
 
09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- Abunda09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- Abunda
 
09 CeoMeeting- Session 4- Sentinext
09 CeoMeeting- Session 4- Sentinext09 CeoMeeting- Session 4- Sentinext
09 CeoMeeting- Session 4- Sentinext
 
09 CeoMeeting- Session 4- Artisan
09 CeoMeeting- Session 4- Artisan09 CeoMeeting- Session 4- Artisan
09 CeoMeeting- Session 4- Artisan
 
09 CeoMeeting- Session 3- Dr. Kishore
09 CeoMeeting- Session 3- Dr. Kishore09 CeoMeeting- Session 3- Dr. Kishore
09 CeoMeeting- Session 3- Dr. Kishore
 
09 CeoMeeting- Session 3- Sime Darby
09 CeoMeeting- Session 3- Sime Darby09 CeoMeeting- Session 3- Sime Darby
09 CeoMeeting- Session 3- Sime Darby
 
09 CeoMeeting- Session 3- Chromatin
09 CeoMeeting- Session 3- Chromatin09 CeoMeeting- Session 3- Chromatin
09 CeoMeeting- Session 3- Chromatin
 
09 CeoMeeting- Session 3- Metahelix
09 CeoMeeting- Session 3- Metahelix09 CeoMeeting- Session 3- Metahelix
09 CeoMeeting- Session 3- Metahelix
 
09 CeoMeeting- Session1- Cobalt
09 CeoMeeting- Session1- Cobalt09 CeoMeeting- Session1- Cobalt
09 CeoMeeting- Session1- Cobalt
 
09 CeoMeeting- Session1- Segetis
09 CeoMeeting- Session1- Segetis09 CeoMeeting- Session1- Segetis
09 CeoMeeting- Session1- Segetis
 
09 CeoMeeting- Session1- Gevo
09 CeoMeeting- Session1- Gevo09 CeoMeeting- Session1- Gevo
09 CeoMeeting- Session1- Gevo
 
09 CeoMeeting- Session 2- Hovid
09 CeoMeeting- Session 2- Hovid09 CeoMeeting- Session 2- Hovid
09 CeoMeeting- Session 2- Hovid
 
09 CeoMeeting- Session2- Battelle
09 CeoMeeting- Session2- Battelle09 CeoMeeting- Session2- Battelle
09 CeoMeeting- Session2- Battelle
 
09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma
 
09 CeoMeeting- Keynote
09 CeoMeeting- Keynote09 CeoMeeting- Keynote
09 CeoMeeting- Keynote
 

Recently uploaded

Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato pptElizangelaSoaresdaCo
 
Fabric RFID Wristbands in Ireland for Events and Festivals
Fabric RFID Wristbands in Ireland for Events and FestivalsFabric RFID Wristbands in Ireland for Events and Festivals
Fabric RFID Wristbands in Ireland for Events and FestivalsWristbands Ireland
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyHanna Klim
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..dlewis191
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsIntellect Design Arena Ltd
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Onlinelng ths
 
Live-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarLive-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarNathanielSchmuck
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024Stephan Koning
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfAnhNguyen97152
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZKanakChauhan5
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxWorkforce Group
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsyasinnathani
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...IMARC Group
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...Brian Solis
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhangmcgroupjeya
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfJohnCarloValencia4
 

Recently uploaded (20)

Investment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV IndustriesInvestment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV Industries
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato ppt
 
Fabric RFID Wristbands in Ireland for Events and Festivals
Fabric RFID Wristbands in Ireland for Events and FestivalsFabric RFID Wristbands in Ireland for Events and Festivals
Fabric RFID Wristbands in Ireland for Events and Festivals
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agency
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking Applications
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Online
 
Live-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarLive-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry Webinar
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZ
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
WAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdfWAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdf
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story points
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhang
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
 

09 CeoMeeting- Session 4- Chakra

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.

Editor's Notes

  1. Short intro to myself and or the company (whatever not said by John).Definition of CRO.“Global company headquartered in Penang”The main point I’d like to make today is that whatever the changes in the macro environment for health care, we as industry participants must focus on delivering benefits to patients.Productivity crisis
  2. I want to show you something and then explain why it is important to the future of human health. But first a little background – one slides of background to be exact.Many of you will be familiar with the concept of using laboratory animal, particularly rodents in drug research. In my line of work discovering and developing new drugs, I have often had to ask myself – are human more like mice, or more like rats, or more like ferrets, or more like mini pigs or like …………….These are important decision we need to make when developing safe effective drugs.Right at the beginning of the R&D for a new drug scientists study human diseases. Then once they understand the diseases they try to create new chemicals to modify or cure these diseases. Once a promising chemical is identified, then the long and difficult process of drug development commences.In some diseases there are good models to predict efficacy – like antibiotics. We understand that bacteria cause the disease and we can use models to check if new antibiotics kill the bacteria. But even then, drugs showing efficacy still only get to market some of the time. Still we consider these models predictive enough.The area we help companies in, schizophrenia is very hard. It is not well understood what causes the disease – some genetic components + some environmental components, there are different types of symptoms which seem to lie on a spectrum and different drugs work only in some patients and all the available drugs have dramatic side effects. There is a compelling need for better drugs in this area and the current models used by industry do not give good productivity so many drugs are taken into development and into clinical trials only to find they do not work – they don’t offer benefit to patients. This process costs 10’s to 100’s of millions of dollars. This represents a colossal waste for companies and no benefit to patients.The global market for antipsychotic medication is ~USD15b, 17 of the top 20 pharma companies have R&D programs in this area and many small pharma and biotech companies also research in this area.So what we have is a way to predict how drugs will behave in people very early in development before lots of time and money are wasted. This is the value proposition we bring to the global pharmaceutical industry.The ‘buzz word’ for what we do is translational medicine – we are definitely on the bench side of the equation of allowing early discoveries to be translated into patient benefits.How this translates into opportunities for Malaysia – “global company headquartered in Penang” theme
  3. Explain VideoFinally it seems like we have a good way to predict which drugs to spend time and money developing.
  4. In any business is it important to understand the full value chain. In our case we have identified we are focused on benefit to patients but in between it is important to understand how the industry works.Explain slide.We need to help each group along the way to get all the way around the chain and have better drugs in the hands of patients.
  5. Pharma industry needs to be more productive with its R&D to address its most pressing challenges. I hope by riding three waves I can get to where I want to be commercially easier.Unmet patient needs – we are helping industry address this issue by helping them be more productive.Outsourcing: way for companies to reduce fixed costs and to access specialist knowledge.Asia: way to get access to the enormous talent pool.Helping patients with a serious and debilitating diseases is a good reason to get out of bed each morning. Along the way, we hope we can also benefit our shareholders, our staff and our community.